Stock Scorecard



Stock Summary for Lilly(Eli) & Company (LLY) - $1,159.70 as of 10/7/2026 6:20:09 PM EST

Total Score

10 out of 30

Safety Score

57 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for LLY

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for LLY

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for LLY

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for LLY

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for LLY (57 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 8
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for LLY

Pfizer (PFE) Trades Below 10x Earnings. Why Does Johnson & Johnson (JNJ) Command More Than Twice the Multiple? 10/7/2026 9:19:00 PM
Eli Lilly (LLY) shareholder Lilly Endowment proposes another sale after $386M in August proceeds. 10/7/2026 7:43:00 PM
General Medicine banks $120M backed by a16z, Eli Lilly and Mercy Health to build out healthcare storefront 10/7/2026 6:13:00 PM
Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis 10/7/2026 4:41:00 PM
Eli Lilly and Co Stock (LLY) Moved Up by 3.94% on Oct 7: Facts Behind the Movement 10/7/2026 4:15:00 PM
Eli Lilly stock gains 2.54 percent on cancer drug news 10/7/2026 2:43:00 PM
FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body 10/7/2026 12:56:00 PM
VivoSim (NASDAQ: VIVS) NAMkind™ Targets FDA’s New Testing Bar 10/7/2026 10:03:00 AM
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more 10/7/2026 9:32:00 AM
VKTX Down 16% in a Month: Time to Invest or Exit the Stock? 10/7/2026 2:31:00 AM

Financial Details for LLY

Company Overview

Ticker LLY
Company Name Lilly(Eli) & Company
Country N/A
Description Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - GENERAL
Most Recent Quarter 6/30/2026
Next Earnings Date 10/29/2026

Stock Price History

Last Day Price 1,159.70
Price 4 Years Ago 355.56
Last Day Price Updated 10/7/2026 6:20:09 PM EST
Last Day Volume 2,131,939
Average Daily Volume 2,323,673
52-Week High 1,292.65
52-Week Low 778.94
Last Price to 52 Week Low 48.88%

Valuation Measures

Trailing PE N/A
Industry PE 45.78
Sector PE 44.87
5-Year Average PE 61.30
Free Cash Flow Ratio 116.32
Industry Free Cash Flow Ratio 53.86
Sector Free Cash Flow Ratio 35.39
Current Ratio Most Recent Quarter 1.35
Total Cash Per Share 9.97
Book Value Per Share Most Recent Quarter 38.00
Price to Book Ratio 30.28
Industry Price to Book Ratio 10.61
Sector Price to Book Ratio 26.31
Price to Sales Ratio Twelve Trailing Months 13.26
Industry Price to Sales Ratio Twelve Trailing Months 3.55
Sector Price to Sales Ratio Twelve Trailing Months 28.44
Analyst Buy Ratings 18
Analyst Strong Buy Ratings 6

Share Statistics

Total Shares Outstanding 891,741,000
Market Capitalization 1,034,152,037,700
Institutional Ownership N/A

Dividends

Ex-Dividend Date 8/14/2026
Previous Dividend Amount 1.7300
Current Dividend Amount 1.7300
Total Years Dividend Increasing Dividend Contender - Increasing for 11 Years
Trailing Annual Dividend Rate 6.69
Trailing Annual Dividend Yield 0.58%
Forward Annual Dividend Rate 6.92
Forward Annual Dividend Yield 0.60%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 0.56%
5-Year Average Dividend Yield 0.78%
1-Year Dividend Growth Rate Percentage 15.33%
3-Year Dividend Growth Rate Percentage 7.39%
5-Year Dividend Growth Rate Percentage 15.27%
All-Time Dividend Growth Rate Percentage 8.78%
Dividend Payout Ratio 22.49%

Income Statement

Quarterly Earnings Growth YOY 26.20%
Annual Earnings Growth 94.90%
Reported EPS 12 Trailing Months 29.74
Reported EPS Past Year 16.93
Reported EPS Prior Year 24.21
Net Income Twelve Trailing Months 26,711,200,000
Net Income Past Year 20,640,000,000
Net Income Prior Year 10,590,000,000
Quarterly Revenue Growth YOY 47.70%
5-Year Revenue Growth 21.58%
Operating Margin Twelve Trailing Months 54.20%

Balance Sheet

Total Cash Most Recent Quarter 8,890,000,000
Total Cash Past Year 7,163,000,000
Total Cash Prior Year 3,268,400,000
Net Cash Position Most Recent Quarter -38,968,000,000
Net Cash Position Past Year -33,705,000,000
Long Term Debt Past Year 40,868,000,000
Long Term Debt Prior Year 28,527,100,000
Total Debt Most Recent Quarter 47,858,000,000
Equity to Debt Ratio Past Year 0.39
Equity to Debt Ratio Most Recent Quarter 0.41
Total Stockholder Equity Past Year 26,535,000,000
Total Stockholder Equity Prior Year 14,192,100,000
Total Stockholder Equity Most Recent Quarter 33,879,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 20,053,900,000
Free Cash Flow Per Share Twelve Trailing Months 22.49
Free Cash Flow Past Year 8,972,000,000
Free Cash Flow Prior Year 414,300,000

Options

Put/Call Ratio 0.90
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.95
MACD Signal -4.89
20-Day Bollinger Lower Band 1,071.93
20-Day Bollinger Middle Band 1,159.72
20-Day Bollinger Upper Band 1,247.52
Beta 0.50
RSI 46.71
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 10/6/2026 3:13:52 AM EST